Company registration number 06801510 (England and Wales)
ROCHESTER GYNAECOLOGY LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024
PAGES FOR FILING WITH REGISTRAR
ROCHESTER GYNAECOLOGY LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
ROCHESTER GYNAECOLOGY LTD
BALANCE SHEET
AS AT
31 JANUARY 2024
31 January 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
5
4,525
6,034
Investments
6
100,000
100,000
104,525
106,034
Current assets
Stocks
1,360
1,360
Debtors
7
67,769
21,359
Cash at bank and in hand
495,961
412,534
565,090
435,253
Creditors: amounts falling due within one year
8
(39,113)
20,733
Net current assets
525,977
455,986
Net assets
630,502
562,020
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
630,402
561,920
Total equity
630,502
562,020

The notes on pages 2 to 5 form part of these financial statements.

For the financial year ended 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 11 October 2024
Professor I T Manyonda
Director
Company registration number 06801510 (England and Wales)
ROCHESTER GYNAECOLOGY LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024
- 2 -
1
Accounting policies
Company information

Rochester Gynaecology Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 19 Manor Way, Purley, Surrey, England, CR8 3BL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT.

 

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and was amortised on a systematic basis over its expected life.

 

 

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% reducing balance
Fixtures and fittings
25% reducing balance
Computers
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Fixed asset investments
ROCHESTER GYNAECOLOGY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2024
1
Accounting policies
(Continued)
- 3 -
1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans are classified as debt, and recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

2
Judgements and key sources of estimation uncertainty
ROCHESTER GYNAECOLOGY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2024
- 4 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was: 1

2024
2023
Number
Number
Total
1
1
4
Intangible fixed assets
Goodwill
£
Cost
At 1 February 2023 and 31 January 2024
140,000
Amortisation and impairment
At 1 February 2023 and 31 January 2024
140,000
Carrying amount
At 31 January 2024
-
0
At 31 January 2023
-
0
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 February 2023 and 31 January 2024
46,023
Depreciation and impairment
At 1 February 2023
39,989
Depreciation charged in the year
1,509
At 31 January 2024
41,498
Carrying amount
At 31 January 2024
4,525
At 31 January 2023
6,034
6
Fixed asset investments
2024
2023
£
£
Other investments other than loans
100,000
100,000
ROCHESTER GYNAECOLOGY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2024
- 5 -
7
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
17,769
18,975
Other debtors
50,000
2,384
67,769
21,359
8
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
1,228
1,798
Corporation tax
27,882
38,563
Other creditors
10,003
(61,094)
39,113
(20,733)
2024-01-312023-02-01false11 October 2024CCH SoftwareCCH Accounts Production 2024.210No description of principal activityProfessor I T Manyondafalsefalse068015102023-02-012024-01-31068015102024-01-31068015102023-01-3106801510core:OtherPropertyPlantEquipment2024-01-3106801510core:OtherPropertyPlantEquipment2023-01-3106801510core:CurrentFinancialInstrumentscore:WithinOneYear2024-01-3106801510core:CurrentFinancialInstrumentscore:WithinOneYear2023-01-3106801510core:CurrentFinancialInstruments2024-01-3106801510core:CurrentFinancialInstruments2023-01-3106801510core:ShareCapital2024-01-3106801510core:ShareCapital2023-01-3106801510core:RetainedEarningsAccumulatedLosses2024-01-3106801510core:RetainedEarningsAccumulatedLosses2023-01-3106801510bus:Director12023-02-012024-01-3106801510core:Goodwill2023-02-012024-01-3106801510core:PlantMachinery2023-02-012024-01-3106801510core:FurnitureFittings2023-02-012024-01-3106801510core:ComputerEquipment2023-02-012024-01-31068015102022-02-012023-01-3106801510core:NetGoodwill2023-01-3106801510core:NetGoodwill2024-01-3106801510core:NetGoodwill2023-01-3106801510core:OtherPropertyPlantEquipment2023-01-3106801510core:OtherPropertyPlantEquipment2023-02-012024-01-3106801510core:WithinOneYear2024-01-3106801510core:WithinOneYear2023-01-3106801510bus:PrivateLimitedCompanyLtd2023-02-012024-01-3106801510bus:SmallCompaniesRegimeForAccounts2023-02-012024-01-3106801510bus:FRS1022023-02-012024-01-3106801510bus:AuditExemptWithAccountantsReport2023-02-012024-01-3106801510bus:FullAccounts2023-02-012024-01-31xbrli:purexbrli:sharesiso4217:GBP